GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » LivaNova PLC (FRA:LIA) » Definitions » Cyclically Adjusted Revenue per Share

LivaNova (FRA:LIA) Cyclically Adjusted Revenue per Share : €23.07 (As of Dec. 2024)


View and export this data going back to 2000. Start your Free Trial

What is LivaNova Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

LivaNova's adjusted revenue per share for the three months ended in Dec. 2024 was €5.617. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €23.07 for the trailing ten years ended in Dec. 2024.

During the past 12 months, LivaNova's average Cyclically Adjusted Revenue Growth Rate was 7.50% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 9.90% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 10.60% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 13.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of LivaNova was 23.20% per year. The lowest was 8.20% per year. And the median was 11.60% per year.

As of today (2025-04-17), LivaNova's current stock price is €31.00. LivaNova's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2024 was €23.07. LivaNova's Cyclically Adjusted PS Ratio of today is 1.34.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of LivaNova was 10.38. The lowest was 1.41. And the median was 4.86.


LivaNova Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for LivaNova's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LivaNova Cyclically Adjusted Revenue per Share Chart

LivaNova Annual Data
Trend Apr15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.16 15.86 19.17 20.25 23.07

LivaNova Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.25 20.78 21.42 20.72 23.07

Competitive Comparison of LivaNova's Cyclically Adjusted Revenue per Share

For the Medical Devices subindustry, LivaNova's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LivaNova's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, LivaNova's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where LivaNova's Cyclically Adjusted PS Ratio falls into.


;
;

LivaNova Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, LivaNova's adjusted Revenue per Share data for the three months ended in Dec. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=5.617/135.1000*135.1000
=5.617

Current CPI (Dec. 2024) = 135.1000.

LivaNova Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201501 2.343 99.200 3.191
201504 2.603 99.900 3.520
201507 2.808 100.000 3.794
201510 2.312 100.300 3.114
201603 5.268 100.400 7.089
201606 5.812 101.000 7.774
201609 5.361 101.500 7.136
201612 1.191 102.200 1.574
201703 4.402 102.700 5.791
201706 4.714 103.500 6.153
201709 4.343 104.300 5.625
201712 4.801 105.000 6.177
201803 4.129 105.100 5.308
201806 4.988 105.900 6.363
201809 4.794 106.600 6.076
201812 5.378 107.100 6.784
201903 4.601 107.000 5.809
201906 5.074 107.900 6.353
201909 4.996 108.400 6.227
201912 5.347 108.500 6.658
202003 4.498 108.600 5.596
202006 3.328 108.800 4.132
202009 4.190 109.200 5.184
202012 4.557 109.400 5.628
202103 4.268 109.700 5.256
202106 4.487 111.400 5.442
202109 4.173 112.400 5.016
202112 4.485 114.700 5.283
202203 4.025 116.500 4.668
202206 4.446 120.500 4.985
202209 4.766 122.300 5.265
202212 4.853 125.300 5.233
202303 4.565 126.800 4.864
202306 5.025 129.400 5.246
202309 4.966 130.100 5.157
202312 5.216 130.500 5.400
202403 5.024 131.600 5.158
202406 5.421 133.000 5.507
202409 5.251 133.500 5.314
202412 5.617 135.100 5.617

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


LivaNova  (FRA:LIA) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

LivaNova's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=31.00/23.07
=1.34

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of LivaNova was 10.38. The lowest was 1.41. And the median was 4.86.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


LivaNova Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of LivaNova's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


LivaNova Business Description

Industry
Traded in Other Exchanges
Address
20 Eastbourne Terrace, London, GBR, W2 6LG
UK-based LivaNova was born of a combination between Cyberonics in the us and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management and heart valve businesses. It derives roughly half of its revenue from the us market, another 21% from Europe, and the remainder from the rest of the world.

LivaNova Headlines

No Headlines